New Disease-Modifying Therapy Brings Good News for Early-Stage Alzheimer’s Patients

Early-stage Alzheimer’s patients have another choice in slowing their disease today, with U.S. Food and Drug Administration (FDA) approval of donanemab. UsAgainstAlzheimer’s celebrates this new choice for patients.

UsAgainstAlzheimer’s Board Member Wins Emmy for Alzheimer’s Documentary

UsAgainstAlzheimer’s chair and co-founder, George Vradenburg, released the following statement in response to board member Greg O’Brien’s recent Emmy win for the documentary, Have You Heard About Greg.

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

More Evidence that “What’s Good for the Heart is Even Better for The Brain” in early-stage Alzheimer’s patients

New study demonstrates how diet, exercise, and other interventions improved brain cognition and function after just 20 weeks

2024 Brain Health Academy

UsAgainstAlzheimer’s is bringing back its Brain Health Academy in May 2024. First launched in 2022, the Academy offers a free, comprehensive virtual program designed to equip healthcare providers and wellness professionals with the necessary tools and resources to reduce the risks associated with Alzheimer’s and related dementias. In collaboration with the American Society on Aging, participants will receive free continuing education credits to enhance their professional development and growth. Learn more about how you can access this resource today.

Listen to the BrainStorm Podcast

Featuring conversations with healthcare providers, researchers, authors, experts, caregivers, and more, BrainStorm is breaking through the silence of Alzheimer's disease. Tune in on the first and third Tuesdays of every month for a new episode, with our host, Meryl Comer.

Good News for Early-Stage Alzheimer’s Patients

Alzheimer’s Documentary Wins Emmy

Become a Member

"What’s Good for the Heart is Even Better for The Brain”

2024 Brain Health Academy

Listen to the BrainStorm Podcast

UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and access to treatments – all regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.


Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.


Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.


Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.



Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • Virginia Biggar

    Remembering ClergyAgainstAlzheimer’s Founder, Dr. Richard L. Morgan

    The movement to end Alzheimer’s disease has lost a giant. Dr. Richard...

    Read more
  • April 07, 2022

    It’s Official: CMS Denies Medicare Coverage to Alzheimer’s Patients

    “Little difference, a lot of uncertainty” in Coverage Determination


    Read more
  • April 01, 2022

    Barragán Leads Colleagues in Call to CMS to Revise Their Non-Coverage Decision for An Entire Class of Alzheimer's Treatments

    Yesterday, Congresswoman Nanette Diaz Barragán led 40 of her colleagues in the...

    Read more
  • March 30, 2022

    Biden Administration and Congress Take a Major Step to Accelerate Research to Treat and Cure Serious Illnesses

    Modeled after DARPA, ARPA-H will incentivize innovative approaches to address some of...

    Read more
  • March 23, 2022

    CMS Proposal Would Leave Millions of Patients Without Access to FDA-approved Alzheimer’s Treatments in CMS Clinical Trials

    Under a proposed rule from the Centers for Medicare and Medicaid Services...

    Read more
  • March 21, 2022

    Warner & Markey Lead Colleagues in a Call to Fairly Evaluate Alzheimer's Treatments

     Sens. Mark R. Warner (D-VA) and Ed Markey (D-MA), Co-Chairs of theCongressional...

    Read more


  • Resources

    2022 Annual Report

  • Resources
    alist 2023

    A-LIST Pulse of the Community – July 2023

  • Resources

    A-LIST Pulse of the Community – November 2022